Mechanism of Action of Empagliflozin
Introduction Empagliflozin is an oral sodium–glucose co-transporter 2 (SGLT2) inhibitor that lowers blood glucose by promoting urinary glucose excretion. It also provides cardiovascular and renal protective benefits, and is approved for type 2 diabetes mellitus, heart failure, and chronic kidney disease. Step-by-Step Mechanism of Action Pharmacokinetic Parameters Parameter Value Route Oral, taken once daily Bioavailability ~78% … Read more
